Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117-Reference-Cited by-同舟云学术

Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117

Published:2015-04-08 Issue:7557 Volume:522 Page:487-491
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Caskey Marina,Klein Florian,Lorenzi Julio C. C.,Seaman Michael S.,West Anthony P.,Buckley Noreen,Kremer Gisela,Nogueira Lilian,Braunschweig Malte,Scheid Johannes F.,Horwitz Joshua A.,Shimeliovich Irina,Ben-Avraham Sivan,Witmer-Pack Maggi,Platten Martin,Lehmann Clara,Burke Leah A.,Hawthorne Thomas,Gorelick Robert J.,Walker Bruce D.,Keler Tibor,Gulick Roy M.,Fätkenheuer Gerd,Schlesinger Sarah J.,Nussenzweig Michel C.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature14411.pdf

Reference40 articles.

1. Mehandru, S. et al. Adjunctive passive immunotherapy in human immunodeficiency virus type 1-infected individuals treated with antiviral therapy during acute and early infection. J. Virol. 81, 11016–11031 (2007)

2. Trkola, A. et al. Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies. Nature Med. 11, 615–622 (2005)

3. Armbruster, C. et al. Passive immunization with the anti-HIV-1 human monoclonal antibody (hMAb) 4E10 and the hMAb combination 4E10/2F5/2G12. J. Antimicrob. Chemother. 54, 915–920 (2004)

4. Klein, F. et al. Antibodies in HIV-1 vaccine development and therapy. Science 341, 1199–1204 (2013)

5. West, A. P., Jr et al. Structural insights on the role of antibodies in HIV-1 vaccine and therapy. Cell 156, 633–648 (2014)

Cited by 665 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV Vaccine Development at a Crossroads: New B and T Cell Approaches;Vaccines;2024-09-12

2. Bispecific Antibodies Provide Broad Neutralization of Emerging Beta-Coronaviruses by Targeting ACE2 and Viral Spikes;Emerging Microbes & Infections;2024-09-11

3. The combination of three CD4-induced antibodies targeting highly conserved Env regions with a small CD4-mimetic achieves potent ADCC activity;Journal of Virology;2024-09-09

4. Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection;Nature Communications;2024-08-29

5. Suppression of viral rebound by a Rev-dependent lentiviral particle in SIV-infected rhesus macaques;Gene Therapy;2024-07-18